Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 567 News Items found Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs Thursday, December 30, 2021 These souped-up versions may help overcome some limitations of existing CAR T cells. Sloan Kettering Institute Year in Review: 10 Noteworthy Science Breakthroughs of 2021 Tuesday, December 21, 2021 Take a look back at some of the biggest science stories from this past year. In the Lab SKI Research Reveals New Insights into Immune Response to Viral Infections — Including COVID-19 Thursday, December 2, 2021 Research from Sloan Kettering Institute immunologists suggests that the body may mount an immune response to respiratory viruses that lasts longer than previously thought. The discovery could impact the timing of COVID-19 vaccinations. Discovery of a Stem-like T Cell in Type 1 Diabetes Holds Potential for Improving Cancer Immunotherapy, Sloan Kettering Institute Scientists Say Tuesday, November 30, 2021 As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy. In the Lab Sloan Kettering Institute Researchers Discover One Way Genetic Mutations Occur During Formation of Eggs and Sperm Wednesday, November 17, 2021 Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation. From Navy Veteran to MSK Cancer Researcher: Matthew Solowsky’s Story Thursday, November 11, 2021 Meet Matthew Solowsky, a Navy veteran and Senior Research Technician in the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center. Finding MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug Thursday, November 11, 2021 A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes. Twenty Years Of Honoring A Legacy: Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research Monday, November 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs Thursday, October 28, 2021 By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening. Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why It’s So Aggressive Thursday, October 14, 2021 Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering. Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page Next › Last page Last »